Tembeling 2.0

Category: Public Health

  • The Silent Toll of Excess Mortality During the COVID-19 Pandemic

    Introduction

    The COVID-19 pandemic has reshaped global health systems, revealing vulnerabilities in healthcare and public health infrastructure. While official COVID-19 death counts capture the immediate impact, excess mortality estimates uncover the pandemic’s broader effects, including indirect deaths caused by disrupted healthcare services and societal changes. This study examines global and regional excess mortality data and emphasises the role of Malaysia’s White Health Paper in preparing for future pandemics.

    Global Excess Mortality Estimates

    Globally, the World Health Organization (WHO) reported approximately 14.9 million excess deaths between January 2020 and December 2021, nearly three times the officially recorded COVID-19 deaths (World Health Organization, 2022). Similarly, the Institute for Health Metrics and Evaluation (IHME) estimated approximately 18.3 million excess deaths during the same period (Wang et al., 2022). These figures underscore the extensive direct and indirect impacts of the pandemic.

    Regional Variations in Excess Mortality

    Excess mortality varied significantly across regions. In Malaysia, a study in The Lancet Regional Health – Western Pacificreported an 8.5% increase in mortality from January 2020 to December 2021, reflecting indirect effects such as healthcare system disruptions and delayed treatments (The Lancet Regional Health – Western Pacific, 2022). In contrast, India reported a 20% increase in excess deaths, highlighting challenges in healthcare access and reporting (The Lancet, 2022). Other countries, such as Brazil and the United States, also faced substantial increases in excess mortality, further demonstrating regional disparities (Faust et al., 2021).

    Indirect Effects of the Pandemic

    Beyond direct COVID-19 fatalities, excess mortality includes deaths exacerbated by the pandemic. Delayed medical treatments due to overwhelmed healthcare systems led to increased deaths from chronic diseases, including cancer and cardiovascular conditions (Maringe et al., 2020). Mental health crises and substance abuse also contributed to rising mortality, particularly among younger populations (Faust et al., 2021).

    The Role of Public Health Specialists and Policymakers in Malaysia

    The pandemic has emphasised the importance of proactive public health leadership. In Malaysia, the White Health Paper provides a comprehensive framework for strengthening healthcare systems and preparing for future pandemics. Key recommendations include:

    1. Strengthening Public Health Infrastructure

    Investments in healthcare infrastructure and workforce capacity are critical. Public health specialists must advocate for equitable healthcare access and improved resource allocation.

    2. Enhancing Surveillance and Data Systems

    Surveillance systems must be upgraded to enable real-time detection and response. Leveraging digital health technologies, such as artificial intelligence and machine learning, is essential for improving data collection and analysis.

    3. Developing Comprehensive Pandemic Preparedness Plans

    Establishing a national pandemic preparedness plan that includes protocols for outbreak management, resource allocation, and community engagement is crucial. This plan should align with the White Health Paper’s strategic vision.

    4. Community Engagement and Health Literacy

    Public health specialists must prioritise health literacy and foster community participation in public health initiatives to ensure compliance during emergencies.

    5. Sustained Investments in Health Systems

    Policymakers must allocate adequate budgets for public health and encourage research in infectious diseases and healthcare innovation.

    Conclusion

    Excess mortality data highlight the devastating effects of the COVID-19 pandemic and the importance of strengthening healthcare systems to mitigate future public health crises. Public health specialists and policymakers in Malaysia must align their efforts with the White Health Paper’s recommendations to ensure preparedness and resilience. By addressing healthcare disparities, improving data systems, and fostering community engagement, Malaysia can build a robust framework for future pandemic responses.

    References

    Faust, J. S., Du, C., Mayes, K. D., et al. (2021). Mortality from drug overdoses, homicides, unintentional injuries, motor vehicle crashes, and suicides during the pandemic in the United States. JAMA, 326(1), 84–86. https://doi.org/10.1001/jama.2021.8012

    Maringe, C., Spicer, J., Morris, M., et al. (2020). The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: A national, population-based, modelling study. The Lancet Oncology, 21(8), 1023–1034. https://doi.org/10.1016/S1470-2045(20)30388-0

    The Lancet. (2022). Estimating excess mortality due to the COVID-19 pandemic: A systematic analysis of COVID-19-related mortality, 2020–21. The Lancet. Retrieved from https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)02796-3/fulltext

    The Lancet Regional Health – Western Pacific. (2022). Excess mortality in Malaysia during the COVID-19 pandemic. The Lancet Regional Health – Western Pacific. Retrieved from https://www.thelancet.com/journals/lanwpc/article/PIIS2666-6065(22)00071-2/fulltext

    Wang, H., Paulson, K. R., et al. (2022). Estimating global excess mortality associated with the COVID-19 pandemic. The Lancet, 399(10334), 1513–1536. https://doi.org/10.1016/S0140-6736(21)02796-3

    World Health Organization. (2022). 14.9 million excess deaths were associated with the COVID-19 pandemic in 2020 and 2021. Retrieved from https://www.who.int/news/item/05-05-2022-14.9-million-excess-deaths-were-associated-with-the-covid-19-pandemic-in-2020-and-2021

  • Rising Medical Costs and the Need for Sustainable Solutions

    The escalating cost of healthcare in Malaysia has become a pressing concern. With private hospitals increasing charges and insurance premiums rising in tandem, many Malaysians find themselves priced out of private care. This growing financial burden is forcing more people to turn to public hospitals, placing unprecedented pressure on a system already operating at capacity.

    The relationship between rising medical charges, soaring insurance premiums, and the strain on public hospitals creates a cycle that is difficult to break. When private hospitals raise their prices, insurers adjust premiums to cover these costs. Patients, especially those in the middle-income group, then face a difficult choice: pay higher premiums or rely on public hospitals for affordable care. This shift burdens public healthcare facilities, which are designed primarily to serve underserved populations. Public hospitals, stretched thin on resources, struggle to maintain quality while catering to increasing demand. This dynamic reflects a growing imbalance in our healthcare system.

    Healthcare Is Not a Commodity

    Healthcare is unlike commodities that people can shop around for. In emergencies or critical situations, decisions are driven by trust, urgency, and necessity rather than cost. Transparency in pricing is a step toward resolving this challenge but cannot be a standalone solution. Displaying prices for procedures, treatments, and medications may empower patients and encourage competition, but this approach does not address deeper systemic issues such as resource allocation, billing complexity, and price inflation.

    The Role of DRG and Case-Mix in Healthcare Reform

    To tackle rising healthcare costs, structured reforms such as Diagnosis-Related Groups (DRG) and case-mix systems offer practical solutions. DRG classifies patients with similar medical conditions and treatment needs into categories, each assigned a fixed payment amount. This system removes incentives to overcharge for services and encourages hospitals to manage their resources efficiently. Hospitals providing care within the payment limits retain the savings, while those exceeding the allocated amount absorb the costs. This model promotes resource optimisation and cost control.

    Case-mix systems complement DRG by measuring hospital performance more broadly. These systems consider the diversity and complexity of cases treated, ensuring that hospitals managing severe or resource-intensive conditions receive adequate funding. For example, a hospital specialising in complex treatments like cancer care naturally requires more resources than one handling routine procedures. Case-mix indices ensure funding reflects the actual care provided and avoid penalising hospitals that manage high-complexity cases.

    Indonesia’s experience with its case-mix system, INA-CBGs (Indonesia Case-Based Groups), introduced in 2014, offers valuable insights. As part of its Jaminan Kesehatan Nasional (JKN) programme, INA-CBGs standardised payments for healthcare services by grouping cases based on clinical characteristics and resource needs. Widely adopted across public and private hospitals under the Health Social Security Agency (BPJS Kesehatan), INA-CBGs have been instrumental in achieving universal health coverage. Despite initial challenges such as inadequate data quality and documentation, the system has proven effective in managing costs and allocating resources efficiently. This example demonstrates the importance of robust data infrastructure and ongoing refinement in implementing such reforms.

    In Malaysia, case-mix systems have been piloted in public hospitals with promising results. Expanding these systems to private hospitals and integrating them with DRG could create a balanced payment structure, rewarding hospitals that provide efficient, high-quality care. By learning from Indonesia and other global examples, Malaysia can adapt these systems to its unique healthcare landscape.

    The Importance of Prevention

    Prevention is one of the most effective yet underutilised strategies for addressing rising healthcare costs. By focusing on preventing diseases before they occur, the overall demand for expensive medical treatments can be significantly reduced. National campaigns promoting healthy lifestyles, regular health screenings, and vaccinations play a vital role in achieving this goal. Public health professionals are pivotal in designing and implementing these initiatives, encouraging individuals to adopt healthier habits and take proactive steps toward better health.

    Incentives for prevention can also be integrated into the healthcare system. Insurers, for instance, could offer lower premiums to individuals who meet health benchmarks or undergo regular screenings. Primary care services could also incorporate preventive care as a routine feature, ensuring timely interventions and reducing the likelihood of costly hospitalisations.

    Improving Public Healthcare Capacity

    As more Malaysians turn to public hospitals for affordable care, it is critical to enhance the capacity of these institutions. Expanding hospital facilities, increasing the healthcare workforce, and upgrading medical equipment are essential steps. Community health clinics can also play a significant role in alleviating the burden on hospitals by managing non-critical cases and providing basic care closer to where people live.

    Digital health solutions such as telemedicine and electronic health records further improve efficiency and accessibility. Telemedicine enables patients to consult doctors remotely, while electronic records ensure better coordination of care, reducing duplication of tests and unnecessary procedures.

    Exploring Public Healthcare Financing

    Sustainable financing is essential for ensuring universal health coverage. Malaysia could consider expanding existing schemes such as MySalam to cover a broader range of services and conditions, providing financial protection to more citizens. Introducing mandatory health insurance contributions, similar to systems in countries like Germany, could help pool resources and distribute costs more equitably.

    Public-private partnerships may also play a role in financing healthcare. Subsidising certain treatments in private hospitals could reduce the burden on public facilities while ensuring patients receive timely care. Any reform in public healthcare financing must balance affordability with access and quality.

    A Call for Collective Action

    Rising healthcare costs are not just an economic issue but a public health challenge. They disproportionately affect vulnerable populations and delay access to essential care. Public health professionals have a critical role in advocating for equitable reforms, educating the public on preventive care, and collaborating with policymakers to design sustainable solutions. Ensuring cost-control measures maintain a balance between affordability and quality is essential for a healthcare system that serves everyone effectively.

    The time to act is now. Structured reforms like DRG and case-mix, alongside transparency, preventive care initiatives, improved public healthcare capacity, and sustainable financing, offer a viable path to a fairer and more efficient healthcare system. By fostering collaboration between stakeholders, Malaysia can ensure healthcare remains a fundamental right for all and not an unattainable privilege for the few.

  • The Alignment of Malaysia’s Health White Paper with the WHO Pathogen Prioritisation Framework for Infectious Disease Preparedness

    Abstract

    Amid rising global threats from infectious diseases, Malaysia’s Health White Paper (MHW) outlines a national strategy for health security and preparedness, aligning with the WHO’s pathogen prioritisation framework for epidemic and pandemic response. This paper examines the MHW’s focus on pathogen family-based research, surveillance, and international collaboration and assesses its alignment with the WHO’s framework, highlighting key pathogens relevant to Malaysia. Through targeted alignment, Malaysia can enhance its health security infrastructure and capacity to manage emerging and endemic infectious disease threats, thus advancing both national resilience and global health security.

    Introduction

    The increasing frequency of global infectious disease outbreaks has heightened the urgency for robust national health security frameworks. Malaysia’s Health White Paper (MHW) sets forth a comprehensive strategy, focused on enhancing surveillance, rapid response capabilities, and public health infrastructure to tackle these challenges. The WHO’s pathogen prioritisation framework complements this strategy, advocating for a pathogen family-based approach that emphasises adaptability and international collaboration to fortify preparedness. This paper examines the alignment between Malaysia’s strategic goals and the WHO framework, illustrating how family-based prioritisation, regional contextualisation, and proactive research strengthen Malaysia’s capacity to address significant infectious disease threats.

    Pathogen Family-Based Prioritisation and Malaysia’s Health Security Goals

    The WHO’s framework prioritises pathogen families, such as Coronaviridae, Flaviviridae, Filoviridae, and Orthomyxoviridae, allowing nations to address a broad range of epidemic threats within high-risk pathogen families (World Health Organization [WHO], 2024). Malaysia’s Health White Paper Pillar 1—Strengthening Health Security—emphasises preparing for both known and emerging threats, including Nipah virus and seasonal influenza. By adopting the WHO’s family-based focus, Malaysia can fortify its capacity for rapid adaptation to pathogens within these families (Ministry of Health Malaysia [MOH], 2024). Priority organisms include SARS-CoV-2 and MERS-CoV (Coronaviridae), Dengue Virus and Zika Virus (Flaviviridae), Ebola Virus (Filoviridae), and various Alphainfluenzavirus strains (Orthomyxoviridae). These pathogens underscore the need for Malaysia to strengthen surveillance and response across related organisms, ensuring preparedness for potential new threats.

    Regional Surveillance and Contextualised Research

    The WHO framework advocates regional adaptation in surveillance, emphasising pathogen transmission dynamics unique to specific environments and social contexts. This approach is critical in Malaysia, where diseases like dengue, influenced by the tropical climate and high vector presence, pose persistent challenges. Malaysia’s Health White Paper Pillar 2—Strengthening Surveillance and Monitoring—promotes data collection tailored to Malaysia’s specific epidemiology, aligning with WHO’s emphasis on regionalised preparedness (MOH, 2024). Expanding digital health tools and genomic surveillance capabilities will improve Malaysia’s outbreak detection and response, reinforcing the alignment of MHW and WHO goals for region-specific, data-driven preparedness.

    Proactive Pathogen Discovery and Prototype Pathogens

    To foster proactive pathogen discovery, the WHO framework encourages research on prototype pathogens, supporting the development of medical countermeasures (MCMs) that can apply broadly across pathogen families (WHO, 2024). Pillar 4—R&D and Innovation—of the MHW aligns with this strategy, endorsing investments in health research that facilitate scalable MCM development. By prioritising prototype pathogens like Nipah virus, Malaysia can ensure that advancements in research and countermeasures extend across multiple pathogens within the same family, enhancing resilience against both anticipated and unknown threats.

    Closing Knowledge Gaps through Localised Research

    Addressing knowledge gaps in transmission, ecology, and host interactions is essential for effective infectious disease management, particularly in Malaysia’s tropical setting, where vector-borne and zoonotic diseases are prominent. The MHW’s Pillar 5—Addressing Health Disparities—emphasises localised public health interventions, bridging critical knowledge gaps in diseases such as leptospirosis and HFMD. This locally focused research aligns with the WHO’s framework, enhancing Malaysia’s capability to develop context-specific interventions based on accurate, regionally relevant data. Prioritising studies on vector ecology, zoonotic interactions, and seasonal transmission dynamics will inform effective policy and public health strategies, meeting both WHO and MHW goals for contextually adapted health responses.

    Collaborative Networks for Research and Development

    The WHO framework calls for robust international and public-private partnerships to expedite research and preparedness efforts. In the MHW, Pillar 3—Public-Private Partnerships—supports collaborative initiatives within Malaysia’s healthcare ecosystem, facilitating quicker R&D processes and global resource sharing. By engaging in international networks, Malaysia can access critical diagnostic tools, expertise, and resources that align with WHO’s collaborative vision. Establishing networks with regional and global research institutions will enhance Malaysia’s preparedness, supporting WHO’s goals of shared knowledge and resources for infectious disease readiness.

    Rapid Deployment of Medical Countermeasures

    In line with WHO’s recommendation for rapid MCM deployment, Malaysia’s Health White Paper Pillar 6—Emergency Response Capabilities—prioritises swift resource mobilisation during health crises. Developing MCM stockpiles and streamlined distribution processes will allow Malaysia to respond effectively to pathogens like dengue and influenza, whose rapid spread necessitates immediate intervention. Rapid deployment strategies for critical supplies align with WHO’s framework, advancing Malaysia’s ability to manage high-risk pathogens.

    Enhanced Capacity Building and Workforce Development

    Effective pathogen preparedness also depends on building healthcare capacity in diagnostics, surveillance, and outbreak management, as emphasised by WHO. The MHW’s Pillar 7—Health Workforce Development—recognises the importance of a well-trained workforce to manage infectious disease threats. By equipping healthcare professionals with skills in diagnostics, genomic analysis, and rapid response, Malaysia supports WHO’s vision of strengthening national capacity for public health resilience. Expanding training programs and building diagnostic expertise will enable Malaysia to maintain an agile and effective response to public health threats, enhancing preparedness at both local and global levels.

    Conclusion

    The alignment between Malaysia’s Health White Paper and the WHO’s pathogen prioritisation framework establishes a comprehensive foundation for infectious disease preparedness. By incorporating the WHO’s recommendations for pathogen family prioritisation, regional surveillance, and collaborative partnerships, Malaysia’s health system is well-positioned to tackle both current and emerging infectious disease challenges. Through targeted initiatives in surveillance, research, and rapid response, Malaysia strengthens its role in global health security while enhancing national resilience to future public health emergencies.

    Disclaimer: This paper includes insights generated by ChatGPT and should be reviewed and validated by experts before any formal use.

    References

    Ministry of Health Malaysia. (2024). Malaysia Health White Paper: Strategic Directions in Health Security.

    World Health Organization. (2024). Pathogen prioritization framework for epidemic and pandemic preparedness. WHO.